Bl. Hsu et al., MODULATION OF T-CELL DEVELOPMENT BY AN ENDOGENOUS ALTERED PEPTIDE LIGAND, The Journal of experimental medicine, 181(2), 1995, pp. 805-810
T cells potentially encounter numerous endogenous peptides during sele
ction in the thymus and in the periphery. We examined the impact of an
endogenous peptide on in vivo T cell development, using a TCR transge
nic mouse model based on a hemoglobin-specific T cell clone. In these
mice, the transgenic beta chains paired with endogenous alpha chains.
This led to a serendipitous primary reactivity to Ser69 peptide, an al
tered peptide ligand of the Hb(d) (64-76) epitope of the parent done.
Two Ser69-reactive T cell populations were identified. A smaller popul
ation of the Ser69-reactive T cells responded both to Ser69 and Hb(d)
(64-76). A majority reacted only to Ser69, and not to Hb(d)(64-76); in
fact, Hb(d)(64-76) was a specific TCR antagonist for these Ser69-only
-reactive T cells. Thus, in this unique experimental system, Ser69 bec
ame an agonist, and Hb(d) (64-76) was an antagonist. Endogenous presen
tation of the antagonist ligand in the thymus selectively eliminated t
he high-avidity cells, while sparing low-avidity cells in the Ser69-re
active T cell repertoire. These results highlight how specificity guid
es developing T cells through a network of ligands and indicate that t
he endogenous peptide pool has a profound effect on T cell development
and repertoire.